company background image
532067 logo

3B Blackbio Dx BSE:532067 Stock Report

Last Price

₹736.00

Market Cap

₹6.3b

7D

-6.4%

1Y

70.1%

Updated

22 Apr, 2024

Data

Company Financials

532067 Stock Overview

3B BlackBio Dx Limited engages in the design, development, manufacturing, and commercialization of PCR based molecular diagnostic kits, PCR enzymes, and PCR reagents in India.

532067 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

3B Blackbio Dx Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for 3B Blackbio Dx
Historical stock prices
Current Share Price₹736.00
52 Week High₹924.00
52 Week Low₹390.00
Beta1.38
1 Month Change-1.06%
3 Month Change-6.85%
1 Year Change70.13%
3 Year Change60.33%
5 Year Change743.55%
Change since IPO4,307.19%

Recent News & Updates

Recent updates

Shareholder Returns

532067IN ChemicalsIN Market
7D-6.4%-2.0%-1.6%
1Y70.1%16.5%45.0%

Return vs Industry: 532067 exceeded the Indian Chemicals industry which returned 16.5% over the past year.

Return vs Market: 532067 exceeded the Indian Market which returned 45% over the past year.

Price Volatility

Is 532067's price volatile compared to industry and market?
532067 volatility
532067 Average Weekly Movement6.3%
Chemicals Industry Average Movement6.4%
Market Average Movement6.9%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 532067 has not had significant price volatility in the past 3 months.

Volatility Over Time: 532067's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197249Dhirendra Dubey3bblackbio.com

3B BlackBio Dx Limited engages in the design, development, manufacturing, and commercialization of PCR based molecular diagnostic kits, PCR enzymes, and PCR reagents in India. Its se11s its PCR based molecular diagnostic kits under the TRUPCR brand to diagnostics labs. The company also offers lateral flow assays under the brand name of TRURAPID and the NGS assays under the brand name of TRUNGS.

3B Blackbio Dx Limited Fundamentals Summary

How do 3B Blackbio Dx's earnings and revenue compare to its market cap?
532067 fundamental statistics
Market cap₹6.32b
Earnings (TTM)₹316.57m
Revenue (TTM)₹787.29m

20.0x

P/E Ratio

8.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
532067 income statement (TTM)
Revenue₹787.29m
Cost of Revenue₹209.12m
Gross Profit₹578.17m
Other Expenses₹261.60m
Earnings₹316.57m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)36.88
Gross Margin73.44%
Net Profit Margin40.21%
Debt/Equity Ratio0.6%

How did 532067 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

7%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.